The global market for bone grafts and substitutes will most likely expand at over 6.3% CAGR from 2023 to 2032.
The bone graft & substitutes market size was estimated at $2.95 bn in 2021.
The significant causes driving demand in the global market for bone grafts and substitutes is the focus on treating fractures to the bones and joints.
With a market share of more than 40% of global sales in 2021, North America dominated the bone graft and substitute industry. The main factors influencing the regional market growth are rising awareness of novel goods that are commercially available and proximity to a fully advanced healthcare system.
The end-use segments in bone grafts and substitutes market are Hospitals, Specialty clinics and Others.
Major players operating in the global bone grafts and substitutes market include AlloSource, Baxter, Johnson & Johnson Services Inc., Smith & Nephew, Stryker, Orthofix Medical Inc., Zimmer Biomet, Medtronic, Geistlich Pharma AG, Dentsply Sirona, Biobank, Wright Medical Group N.V., Globus Medical, BioHorizons, Integra LifeSciences, Arthrex Inc., Artoss Inc., ACE Surgical Supply Co. Inc., ACE Surgical Supply Co. Inc., Institut Straumann AG, NuVasive Inc. and others.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved